February 26, 2025
Navigating the Implications of Proposed Changes to GLP-1 Medication Coverage
Changes to GLP-1 Medication Coverage The Centers for Medicare & Medicaid Services (CMS) has proposed changes to Medicare and Medicaid coverage for glucagon-like peptide-1 (GLP-1) medications, which are currently covered primarily for the treatment of type 2 diabetes. These medications have also gained attention for their effectiveness in managing obesity, although coverage for weight loss […]
